High Vista Strategies LLC Aclaris Therapeutics, Inc. Transaction History

High Vista Strategies LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	SELL	$7.89 - $10.64 $881,313 - $1.19 Million	-111,700 Reduced 56.47%	86,103 $892,000
Q1 2023 May 15, 2023	BUY	$7.07 - $17.95 $72,000 - $182,802	10,184 Added 5.43%	197,803 $1.6 Million
Q4 2022 Feb 14, 2023	SELL	$14.33 - $18.37 $432,751 - $554,755	-30,199 Reduced 13.86%	187,619 $2.95 Million
Q3 2022 Nov 14, 2022	BUY	$13.07 - $18.22 $3,790 - $5,283	290 Added 0.13%	217,818 $3.43 Million
Q2 2022 Aug 15, 2022	BUY	$10.16 - $17.08 $602,335 - $1.01 Million	59,285 Added 37.46%	217,528 $3.04 Million
Q1 2022 May 16, 2022	BUY	$9.74 - $17.92 $448,848 - $825,807	46,083 Added 41.09%	158,243 $2.73 Million
Q4 2021 Feb 14, 2022	BUY	$12.27 - $18.49 $235,093 - $354,268	19,160 Added 20.6%	112,160 $1.63 Million
Q3 2021 Nov 15, 2021	BUY	$13.38 - $18.8 $713,488 - $1 Million	53,325 Added 134.4%	93,000 $1.68 Million
Q2 2021 Aug 16, 2021	BUY	$17.08 - $29.6 $677,648 - $1.17 Million	39,675 New	39,675 $697,000

50.7M

30.6K

Ticker ACRS
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 66,671,800
Market Cap $193M
Description
Aclaris Therapeutics, Inc. operates a clinical-stage biopharmaceutical company, develops novel drug candidates for immune-inflammatory diseases in the United States. It operates through two segments: Therapeutics and Contract Research. The Therapeutics segment is involved in identifying and developing innovative therapies to address significant ...

Get notified when there are updates to the investment portfolio of High Vista Strategies LLC, based on Form 13F filings with the SEC.

Stay updated on High Vista Strategies LLC with notifications on news.